USPTO trademark

LONQURJA

AllowedUSPTOWord markClass 5

"LONQURJA" is a word mark owned by Intellia Therapeutics, Inc., filed at the USPTO on August 25, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View Intellia Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
LONQURJA trademark as filed
As filed with the USPTO
Status
Allowed
Since June 23, 2026
Filed
August 25, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99356583
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns LONQURJA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Intellia Therapeutics, Inc.

NTLA · Cambridge, United States

20 trademarks in the portfolioView company

Representative

Karen K. Won

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C

Goods and services

What the mark covers

The products and services LONQURJA is filed for, grouped by Nice class.

  • Pharmaceutical and biological preparations for the treatment of hereditary angioedema (HAE); Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for use with protein disorders and genetic diseases; Intravenous injectable gene therapy preparations for treating and managing swelling attacks; Therapeutic agents in the nature of CRISPR/Cas9 protein with guide RNAs targeting the KLKB1 gene to reduce production of plasma prekallikrein and control bradykinin generation

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Applicant/correspondence changes (non-responsive) entered
  3. Teas change of owner address received
  4. Teas change of correspondence received
  5. Attorney/dom.rep.revoked and/or appointed
  6. Teas revoke/app/change addr of atty/dom rep received
  7. Noa e-mailed - sou required from applicant
  8. Official gazette publication confirmation e-mailed
  9. Published for opposition
  10. Notification of notice of publication e-mailed

10 earlier steps on the official record.

FAQ

About LONQURJA

Who owns the trademark "LONQURJA"?

The USPTO trademark "LONQURJA" (application 99356583) is owned by Intellia Therapeutics, Inc.

What is the status of "LONQURJA"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LONQURJA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b19-184c-77af-b76f-e319af2f7d66
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b19-184c-77af-b76f-e319af2f7d66",
  "object": "trademark",
  "mark_text": "LONQURJA",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99356583",
  "filing_date": "2025-08-25",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Intellia Therapeutics, Inc.",
      "entity_id": "ent_019eb70a-ad62-7032-a246-031d34afc7b9"
    }
  ]
}